IP Verse

Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations

Patent No. EP4223296 (titled "Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations") was filed by H Lundbeck on Jun 27, 2013. The application was issued on Jan 29, 2025.

Patent Summary

UPC Cases New

Latest UPC cases involving this patent.

Case NumberFiling DatePlaintiffProceeding Type
UPC_CFI_0001587/2025Nov 14, 2025BiogaranRevocation

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIOGARANOct 29, 2025CASALONGA
ALFRED E TIEFENBACHEROct 27, 2025HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4223296

H LUNDBECK
Application Number
EP23163177A
Filing Date
Jun 27, 2013
Status
Granted And Under Opposition
Dec 26, 2024
Publication Date
Jan 29, 2025
External Links
Slate, Register , Google Patents